Clinical Trial

OCT in Endovascular Recanalization of Chronic Carotid Artery Occlusion

Study acronym: OCT CICAO
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Chronic carotid artery occlusion is an important cause of ischemic stroke. Even with best medical therapy, patients with symptomatic disease may continue to have recurrent ipsilateral transient ischemic attack or ischemic stroke and may have a substantial burden of cognitive decline. Advances in guidewires, microcatheters, distal protection devices, and endovascular techniques have improved the technical success of CCAO recanalization; however, the overall clinical benefit of endovascular therapy appears highly dependent on patient selection and intra-procedural decision-making. During endovascular recanalization, once the guidewire crosses the occluded segment, the operator often must determine whether intraluminal thrombus, dissection, plaque debris, or other lesions are present. Digital subtraction angiography is essential for lumen and flow assessment but cannot reliably characterize the tissue composition or age of intraluminal filling defects. OCT provides high-resolution intraluminal imaging and may improve thrombus identification and lesion assessment in this setting.
Trial Details
NCT Number NCT07740408
Lead Sponsor RenJi Hospital
Conditions Chronic Internal Carotid Artery Occlusion, Carotid Artery Occlusion
Enrollment 60 participants
Start Date 2025-07-01
Primary Completion 2028-07-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-31